CTRI/2023/01/048685已完成未知
Evaluation of irritation potential of Skin Care & Hair care formulations on healthy human subjects
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Female and male Asian Indian subjects.
- •Healthy human subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory check up)
- •Between 18 and 65 years of age.
- •Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scarâ?¦.)
排除标准
- •1 For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months
- •2 Having refused to give his/her assent by not signing the consent form
- •3 Taking part in another study liable to interfere with this study
- •4 Being diabetic.
- •5 Being asthmatic.
- •6 Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
- •7 Having cutaneous hypersensitivity (except in the case of studies with evaluation of sensitive skin).
- •8 Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products.
- •9 Having undergone a surgery requiring a general anaesthesia of more than one hour in the past 6 months.
- •10 Having changed his/her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
- •11 The day of the patch application: no cosmetic product must be used (test site clean with water only). Refusing to follow the restrictions below during the study: - For female: Do not become pregnant nor breastfeed. - Do not take part in another study liable to interfere with this study - Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, and antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). - Do not change his/her cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit
- •12 Having eczema, psoriasis, lichen plan, vitiligo whatever the considered area
- •13 Having disorder of the healing (whatever the considered area) • Having a rhinitis, allergic conjunctivitis, or rhino sinusitis
- •14 Having an allergy to perfumes and/or conservatives in cosmetic products
- •15 Having an allergy to plaster
- •16 Having a food allergy
- •17 Having a cardiovascular pathology (taking a beta blocker treatment)
- •18 Having immunosuppressive drugs, such as cyclophosphamide, methotrexate, azathioprine, etc.
- •19 Taking a retinoid-based treatment by general or oral route
- •20 Taking specific treatment on the back.
- •21 Having taken an anti-histaminic treatment in the last 2 weeks preceding the start of the study
- •22 Having miliaria (prickly heat) on the back.
- •23 Presenting too many naevus on the back
- •24 Having high pilosity on the back.
- •25 Refusing to follow the restrictions below during the study: - During the first 24 hours (after patch application), neither cosmetic products nor water must be applied on the back. - Till the follow up period of until T8 days, only water is accepted from the first reading i.e., T2 days (24 hours after the patch removal). - Do not practice an intensive sport activity during the first 24 hours (until the removal of the patches) - Do not expose the back to the sun.
研究者
相似试验
尚未招募
Unknown
Safety assessment of cosmetic productsCTRI/2023/12/060894Mosaic wellness pvt ltd
已完成
不适用
Safety evaluation of skin care formulatioCTRI/2022/10/046433Mosaic wellness pvt ltd26
已完成
不适用
Safety assessment of skin care formulationsCTRI/2021/12/038363Mosaic wellness pvt ltd24
尚未招募
不适用
Safety assessment of Cosmetic ProductCTRI/2022/11/047296AVIMEE HERBAL PRIVATE LIMITED
尚未招募
不适用
Safety assessment of products on skiCTRI/2021/05/033341Amvigor Organics Pvt Ltd